Final IP Reconciliation and Accountability in Clinical Trials
Final IP Reconciliation and Accountability During Site Close-Out Visits As a clinical trial approaches completion at an investigational site, one of the most critical responsibilities of the Clinical Research Associate (CRA) is to ensure proper reconciliation and accountability of the Investigational Product (IP). This process safeguards regulatory compliance, maintains the integrity of the study’s supply…
Read More “Final IP Reconciliation and Accountability in Clinical Trials” »